Print

Takeda Pharmaceutical Co. Ltd. (TKPYY) Cracks Down on CMO Plant Suspended After Manufacturing Violation  
2/20/2013 7:14:29 AM

Takeda says it will help Nihon Pharmaceuticals bring manufacturing operations up to code after Japanese regulators order the CMO to halt production and recall one lot of its vitamin B1 shot.
//-->